Latest Asx Company Filings News

Dreadnought Resources has successfully extended the strike of its high-grade Metzke’s Find gold resource at the Illaara Project, delivering promising assay results from a recent drilling campaign that could significantly boost near-term production ounces.

Everest Metals Corporation has released further assay results confirming thick, high-grade rubidium mineralisation at its Mt Edon project in Western Australia, underpinning an upcoming resource upgrade. The company’s collaboration with CSIRO is refining processing strategies to enhance recovery rates.

Aspermont Limited reported a $1.49 million net cash outflow in Q1 FY26 but maintains its forecast to become cash generative by Q3, supported by strong trading performance and strategic progress.

GreenTech Metals has completed a transformative acquisition of a majority interest in the Munni Munni platinum group elements project in Western Australia, with drilling underway to verify and expand historic resources.

Resources & Energy Group Limited (ASX, REZ) has initiated reverse circulation drilling at its East Menzies Gold Project, aiming to expand known gold mineralisation and explore new targets at Gigante Grande and Goodenough deposits.

FireFly Metals has agreed to sell its Ontario gold assets, including a 70% stake in the Pickle Crow Project, to Bellavista Resources for up to A$86.1 million in scrip. FireFly shareholders will receive Bellavista shares, maintaining exposure to the assets while FireFly focuses on its copper-gold ambitions.

First Au Limited has reported strong initial assay results from its Phase 3 drilling at the Gimlet Gold Project, confirming high-grade gold mineralisation and setting the stage for a resource upgrade.

Hydrix Limited has amended its quarterly cash flow report, revealing stronger customer receipts and a stable cash position supported by robust financing facilities.

Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.

FortifAI Limited has completed its acquisition of FastAI Pty Ltd, gaining control of the innovative Nol8 technology and appointing seasoned executive Yosef Keret as director and Celerriem CEO.

Emyria Limited reports that approximately 67% of patients treated for PTSD remain in remission over 12 months post-treatment, highlighting the potential for lasting recovery and cost-effective care.

F.F.I. Holdings anticipates a modest decline in half-year profit, citing one-off lease expenses despite steady food operations.